Orticumab recognizes and binds a specific epitope of oxLDL, malondialdehyde (MDA)-modified apolipoproteinB-100.
What epitope does orticumab bind on oxLDL?
Share This Story, Choose Your Platform!
About the Author: Ben Huizinga
Dr. Peter Libby appointed to the Abcentra Board of Directors. Read the Article.
© 2025 Abcentra LLC • All Rights Reserved • Terms of Use • Privacy Policy
Abcentra's pharmaceutical products are investigational and not FDA approved.